{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:32:47Z","timestamp":1793917967772,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijid.2024.107023","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T03:02:14Z","timestamp":1711681334000},"page":"107023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7610-6467","authenticated-orcid":false,"given":"Salini","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4982-4547","authenticated-orcid":false,"given":"Nicole","family":"Cossrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4651-2012","authenticated-orcid":false,"given":"Kalvin C.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-116X","authenticated-orcid":false,"given":"Meghan","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5291-5446","authenticated-orcid":false,"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107023_bib0001","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40121-022-00613-z","article-title":"Estimates of the health and economic burden of pneumococcal infections attributable to the 15-valent pneumococcal conjugate vaccine serotypes in the USA","volume":"11","author":"Owusu-Edusei","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijid.2024.107023_bib0002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2024.107023_bib0003","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/vaccines11040748","article-title":"Burden of acute-care hospitalization for community-acquired pneumonia in Canadian adults aged 50 years or older: focusing on most responsible diagnosis tells only part of the story","volume":"11","author":"Grajales Beltr\u00e1n","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2024.107023_bib0004","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report, Emerging Infections Program Network, Streptococcus pneumoniae, 2019. https:\/\/www.cdc.gov\/abcs\/downloads\/SPN_Surveillance_Report_2019.pdf, [accessed 7 September 2023]."},{"issue":"suppl 1","key":"10.1016\/j.ijid.2024.107023_bib0005","doi-asserted-by":"crossref","first-page":"S738","DOI":"10.1093\/ofid\/ofaa439.1655","article-title":"Impact of 13-valent pneumococcal conjugate vaccine (PCV13) on non-bacteremic pneumococcal pneumonia (NBPP) among adults in the United States, 2013-2017","volume":"7","author":"Gierke","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1111","article-title":"Incidence and estimated vaccine effectiveness against hospitalizations for all-cause pneumonia among older US adults who were vaccinated and not vaccinated with 13-valent pneumococcal conjugate vaccine","volume":"5","author":"Hsiao","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2024.107023_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101271","article-title":"Non-invasive pneumococcal pneumonia due to vaccine serotypes. A systematic review and meta-analysis","volume":"44","author":"Lansbury","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2024.107023_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.ijid.2024.107023_bib0009","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2024.107023_bib0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijid.2019.10.005","article-title":"Impact of vaccines on antimicrobial resistance","volume":"90","author":"Buchy","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0011","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7774\/cevr.2021.10.2.81","article-title":"Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2021","journal-title":"Clin Exp Vaccin Res"},{"key":"10.1016\/j.ijid.2024.107023_bib0012","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/jiac154","article-title":"Impact of pneumococcal conjugate vaccines on antibiotic-nonsusceptible invasive pneumococcal disease in the United States","volume":"226","author":"Bajema","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0013","doi-asserted-by":"crossref","first-page":"ofac420","DOI":"10.1093\/ofid\/ofac420","article-title":"A multicenter evaluation of trends in antimicrobial resistance among Streptococcus pneumoniae isolates from adults in the United States","volume":"9","author":"Mohanty","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0014","doi-asserted-by":"crossref","first-page":"ofab063","DOI":"10.1093\/ofid\/ofab063","article-title":"A multicenter evaluation of the US prevalence and regional variation in macrolide-resistant S. pneumoniae in ambulatory and hospitalized adult patients in the United States","volume":"8","author":"Gupta","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1309\/502AUPR8VE67MBDE","article-title":"A laboratory-based, hospital-wide, electronic marker for nosocomial infection: the future of infection control surveillance?","volume":"125","author":"Brossette","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ijid.2024.107023_bib0016","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2024.107023_bib0017","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/civ1214","article-title":"Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia","volume":"62","author":"Gadsby","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0018","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.vaccine.2022.02.081","article-title":"Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay","volume":"40","author":"LeBlanc","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107023_bib0019","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12913-016-1432-4","article-title":"Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions","volume":"16","author":"Weycker","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ijid.2024.107023_bib0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/thoraxjnl-2012-203106","article-title":"Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia","volume":"68","author":"Naucler","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2024.107023_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijid.2015.05.003","article-title":"Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence","volume":"37","author":"Curcio","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0022","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.vaccine.2010.05.030","article-title":"Clinical and economic burden of pneumococcal disease in older US adults","volume":"28","author":"Weycker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107023_bib0023","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-018-3326-z","article-title":"Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107023_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287581","article-title":"Clinical and economic burden of pneumococcal disease among adults in Sweden: a population-based register study","volume":"18","author":"Zarabi","year":"2023","journal-title":"PLoS One"},{"issue":"suppl 4","key":"10.1016\/j.ijid.2024.107023_bib0025","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/jac\/dkz286","article-title":"Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16","volume":"74","author":"Golden","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.107023_bib0026","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2019.09.065","article-title":"Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: emergence of drug-resistant non-vaccine serotypes","volume":"38","author":"Kim","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107023_bib0027","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/jac\/dkab167","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on otitis media and acute sinusitis epidemiology in British Columbia, Canada","volume":"76","author":"Vadlamudi","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2024.107023_bib0028","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1016\/j.vaccine.2022.06.024","article-title":"Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States","volume":"40","author":"Huang","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107023_bib0029","unstructured":"Hung MC, Srivastav A, Lu PJ, Black CL, Jatlaoui TC, Lindley MC, et al. Vaccination coverage among adults in the United States, National Health Interview Survey, 2021. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/vaccination-coverage-adults-2021.html, 2023 [accessed 26 September 2023]."},{"key":"10.1016\/j.ijid.2024.107023_bib0030","article-title":"Vaccine update and barriers to vaccination among at-risk adult populations in the US","volume":"18","author":"Kolobova","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2024.107023_bib0031","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2194779","article-title":"Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions","volume":"19","author":"Liu","year":"2023","journal-title":"Hum Vaccin Immunother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:01:35Z","timestamp":1715756495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"alternative-id":["S1201971224000948"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107023","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. and The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107023"}}